<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="name">Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma</item><item key="sample_count">10</item><item key="tags"><item>cancer</item><item>carcinoma</item><item>cell</item><item>head</item><item>head and neck squamous cell carcinoma</item><item>insulin</item><item>neck</item><item>squamous</item><item>squamous cell</item><item>squamous cell carcinoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-9600</item><item key="id">5048</item><item key="slug">insulin-like-growth-factor-1-receptor-inhibitor-am</item><item key="factor_count">0</item></item><item><item key="name">Integrated bioinformatic and wet-lab approach to identify potential oncogenic networks in neuroblastoma: MEIS1</item><item key="sample_count">5</item><item key="tags"><item>cancer</item><item>cell</item><item>neuroblastoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-17827</item><item key="id">3399</item><item key="slug">integrated-bioinformatic-and-wet-lab-approach-to-4</item><item key="factor_count">2</item></item><item><item key="name">Integrated molecular genetic profiling of pediatric-high grade gliomas reveals key differences with adult disease</item><item key="sample_count">53</item><item key="tags"><item>cancer</item><item>chromosome</item><item>cranial</item><item>disease</item><item>glioma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-19578</item><item key="id">3527</item><item key="slug">integrated-molecular-genetic-profiling-of-pediatri</item><item key="factor_count">3</item></item><item><item key="name">Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer [mRNA]</item><item key="sample_count">32</item><item key="tags"><item>cancer</item><item>cell</item><item>composite</item><item>disease</item><item>genome</item><item>pancreas</item><item>pancreatic cancer</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-32676</item><item key="id">4251</item><item key="slug">integrative-survival-based-molecular-profiling-of</item><item key="factor_count">4</item></item><item><item key="name">Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome</item><item key="sample_count">50</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>genome</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-23593</item><item key="id">3779</item><item key="slug">intratumor-heterogeneity-and-precision-of-microarr</item><item key="factor_count">4</item></item><item><item key="name">In vivo NCL-targeting affects breast cancer aggressiveness through miRNA regulation [Affymetrix]</item><item key="sample_count">6</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>protein</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-41972</item><item key="id">2702</item><item key="slug">in-vivo-ncl-targeting-affects-breast-cancer-aggres</item><item key="factor_count">0</item></item><item><item key="name">Involvement of the TGF-&#946; and &#946;-catenin pathways in pelvic lymph node metastasis in early stage cervical cancer</item><item key="sample_count">39</item><item key="tags"><item>cancer</item><item>carcinoma</item><item>cell</item><item>cervical cancer</item><item>class</item><item>glycosphingolipid</item><item>lymph</item><item>lymph node</item><item>pelvic lymph node</item><item>squamous</item><item>squamous cell</item><item>squamous cell carcinoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-26511</item><item key="id">3914</item><item key="slug">involvement-of-the-tgf-and-catenin-pathways-in-pel</item><item key="factor_count">3</item></item><item><item key="name">IPH-926 human lobular breast cancer cells</item><item key="sample_count">1</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>line</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-28089</item><item key="id">4005</item><item key="slug">iph-926-human-lobular-breast-cancer-cells</item><item key="factor_count">0</item></item><item><item key="name">Isocitrata Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/mir-200-Dependent Epithelial Mesenchymal Transition (EMT)</item><item key="sample_count">18</item><item key="tags"><item>cancer</item><item>cell</item><item>epithelial cell</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-41802</item><item key="id">4602</item><item key="slug">isocitrata-dehydrogenase-idh-mutations-promote-a-r</item><item key="factor_count">2</item></item><item><item key="name">Isolation and characterization of a metastatic hybrid cell line generated by ER negative and ER positive breast cancer cells in mouse bone marrow</item><item key="sample_count">9</item><item key="tags"><item>bone</item><item>bone marrow</item><item>breast</item><item>breast tumor</item><item>cancer</item><item>cell</item><item>estrogen</item><item>line</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-27515</item><item key="id">3979</item><item key="slug">isolation-and-characterization-of-a-metastatic-hyb</item><item key="factor_count">2</item></item></data></biogps>
